Abstract
A comparison was made of sirolimus–eluting stents and bare stents as an effective means of treatment of stenosis in crural arteries. Patients were randomly divided into two groups: (1) patients treated with sirolimus-eluting stents and (2) patients treated with bare stents. Each group consisted of 25 patients, and every patient had one stent implanted. All patients showed symptoms of ischemia of the peripheral arteries, classified according to the Rutherford scale into categories 3, 4, and 5. All patients were examined 24 h before and 24 h and 6 months after the intervention. The results were analyzed according to clinical, hemodynamic, and angiographic criteria. Technically, the procedure was successful in 100% of cases, and both groups presented an equal improvement in clinical and hemodynamic parameters. The follow-up angiographic examination demonstrated a significantly lower rate of restenosis among the sirolimus-eluting stent group (4, 16%) versus the bare stent group (19, 76%) (p < 0.001), with lower target lesion revascularization in 3 (12%) versus 14 (56%) (p < 0.05), respectively. Quantitative angiography demonstrated that all variables used to assess restenosis were superior for sirolimus-eluting stents 6 months after intervention: late lumen loss 0.46 ± 0.72 versus 1.70 ± 0.94 (p < 0.001) and minimal lumen diameter 2.25 ± 0.82 versus 0.99 ± 1.08 (p < 0.001). Results of this study reveal that the use of sirolimus-eluting stents decreases the risk of restenosis in comparison to standard stents.
Similar content being viewed by others
References
ICAI Study Group (1996) A prospective epidemiological survey of the natural history of chronic critical leg ischemia. Eur J Vasc Endovasc Surg 11:112–120
Schillinger M, Exner M, Mlekusch W, Haumer M, Rumpold H, Ahmadi R et al (2003) Endovascular revascularization below the knee: 6-month results and predictive value of C-reactive protein level. Radiology 227:419–425
Balmer H, Mahler F, Do DD, Triller J, Baumgartner I (2002) Balloon angioplasty in chronic critical limb ischemia: factors affecting clinical and angiographic outcome. J Endovasc Ther 9:403–410
Holm J, Arfvidsson B, Jivegard L, Lundgren F, Lundholm K, Scherstén T et al (1991) Chronic lower limb ischaemia. A prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA). Eur J Vasc Surg 5:517–522
Nasr MK, McCarthy RJ, Hardman J, Chalmers A, Horrocks M (2002) The increasing role of percutaneous transluminal angioplasty in the primary management of critical limb ischaemia. Eur J Vasc Endovasc Surg 23:398–403
Ingle H, Nasim A, Bolia A, Fishwick G, Naylor R, Bell PR (2002) Subintimal angioplasty of isolated infragenicular vessels in lower limb ischemia:long-term results. J Endovasc Ther 9:411–416
Matsi PJ, Manninen HI, Suhonen MT, Pirinen AE, Soimakallio S (1993) Chronic critical lower-limb ischemia: prospective trial of angioplasty with 1–36 months follow–up. Radiology 188:381–387
Söder HK, Manninen HI, Jaakkola P, Matsi PJ, Räsänen HT, Kaukanen E et al (2000) Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Inter Radiol 11:1021–1031
Bailey CM, Saha S, Magee TR, Galland RB (2003) A 1 year prospective study of management and outcome of patients presenting with critical lower limb ischaemia. Eur J Vasc Endovasc Surg 25:131–134
Bosiers M, Deloose K, Verbist J, Peeters P (2006) Percutaneous transluminal angiplasty for treatmentof below-the-knee critical limb ischemia. Early autcomes following the use of sirolimus-eluting stents. J Cardiovasc Surg 47:171–176
Tsetis D, Belli AM (2004) The role of infrapopliteal angioplasty. Br J Radiol 77:1007–1015
Dorros G, Jaff MR, Dorros AM, Mathiak LM, He T (2001) Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia. Circulation 104:2057–2206
Duda SH, Pusich B, Richter G, Landwehr P, Oliva VL, Tielbeek A et al (2002) Sirolimus eluting stents for the treatment of obstructive superfical femoral artery disease: 6-months results. Circulation 106:1505–1509
Löfberg AM, Lörelius LE, Karacagil S, Westman B, Almgren B, Bergqvist D (1996) The use of below-knee percutaneous transluminal angioplasty in arterial occlusive disease causing chronic critical limb ischemia. Cardiovasc Intervent Radiol 19:317–322
Krankenberg H, Sorge I, Zeller T, Tübler T (2005) Percutaneous transluminal angioplasty of infrapopliteal arteries in patients with intermittent claudication: acute and 1-year results. Catheter Cardiovasc Interv 64:12–17
Feiring AJ, Wesolowski AA, Lade S (2004) Primary stent-supported angioplasty for testment of below-knee critical limb ischemia and severe claudication. Am Coll Cardiol 44:2307–2314
Bull PG, Mendel H, Hold M, Schlegl A, Denck H (1992) Distal popliteal and tibioperoneal transluminal angioplasty: long-term follow-up. J Vasc Interv Radiol 3:45–53
Siablis D, Karnabatidis D, Katsanos K, Kagadis GC, Kraniotis P, Diamantopoulos A et al (2007) Sirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limbischemia: enduring 1-year angiographic and clinical benefit. J Endovasc Ther 14:241–250
Scheinert D, Ulrich M, Scheinert S, Sax J, Braunlich S, Biamino G et al (2006) Comparison of sirolimus-eluting vs bare-metal stents for the treatment of infrapopliteal obstructions. EuroIntervention 2:169–174
Kimura T, Yokoi H, Nakagawa Y, Tamura T, Kaburagi S, Sawada J (1996) Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med 334:561–566
Klugherz BD, DeAngelo DL, Kim BK, Herrmann HC, Hirshfeld JW, Kolansky DM (1996) Three-year clincal follow-up after Palmaz-Schatz stenting. J Am Coll Cardiol 27:1185–1191
Mauri L, Orav EJ, Kuntz RE (2005) Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation 111:3435–3442
Mauri L, Orav EJ, Candia SC, Cutlip DE, Kuntz RE (2005) Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials. Circulation 112:2833–2839
Shiran A, Mintz GS, Waksman R, Mehran R, Abizaid A, Kent KM et al (1998) Early lumen loss afler treatment of in-stent restenosis. Circulation 98:200–203
Hoffmann R, Mintz GS (2000) Coronary in-stent restenosis – predictors, treatment and prevention. Eur Heart J 21:1739–1749
Danielsson G, Albrechtsson U, Norgren L, Danielsson P, Ribbe E, Thörne J et al (2001) Percutaneous transluminal angioplasty of crural arteries: diabetes and other factors influencing outcome. Eur J Vasc Endovasc Surg 21:432–436
Mlekusch W, Schillinger M, Sabeti S, Maca T, Ahmadi R, Minar E (2002) Clinical outcome and prognostic factors for ischaemic ulcers treated with PTA in lower limbs. Eur J Vasc Endovasc Surg 24:176–181
Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ et al (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326:381–386
Belli AM, Cumberland DC, Knox AM, Procter AE, Welsh CL (1990) The complication rate of percutaneous peripheral balloon angioplasty. Clin Radiol 41:380–283
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Falkowski, A., Poncyljusz, W., Wilk, G. et al. The evaluation of primary stenting of sirolimus-eluting versus bare-metal stents in the treatment of atherosclerotic lesions of crural arteries. Eur Radiol 19, 966–974 (2009). https://doi.org/10.1007/s00330-008-1225-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-008-1225-1